IGF-1 LR3 is a potent, long-acting synthetic version of insulin-like growth factor 1 (IGF-1), studied for muscle growth and recovery
When do I take levothyroxine and my GLP-1
[PMID: 40617160] PubMed record related to this compound for laboratory literature review
The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (74)
A 2026 UK evidence review of TPO antibodies, the T3-BDNF-HGF axis, NICE NG145, levothyroxine, T3 liothyronine and Hashimoto's Read the full review Neuroscience 29 May 2026 Dihexa for Lupus (SLE) Brain Fog & Neuropsychiatric Lupus (NPSLE): The 2026 UK Review Rigorous 2026 UK review of Dihexa for lupus (systemic lupus erythematosus, SLE) brain fog and neuropsychiatric lupus (NPSLE)
GLP-1 medications can cause side effects